Short answer: hCG is an FDA-approved injection that acts like LH directly on the testes.1 Enclomiphene is an oral SERM that blocks estrogen feedback at the brain so the pituitary releases more LH and FSH; it is not FDA approved (FDA declined it in 2015).2 In trials, enclomiphene raised testosterone while keeping sperm counts, unlike testosterone gel.3
| hCG (Novarel, Pregnyl) | Enclomiphene | |
|---|---|---|
| Mechanism | Acts on the LH receptor in the testes | Selective estrogen receptor modulator; raises the body's own LH and FSH4 |
| Approval status | FDA approved, including for selected hypogonadotropic hypogonadism in males1 | Not FDA approved; complete response letter December 20152. FDA 503A Category 1 (under evaluation)5 |
| Dosing schedule | Label (male hypogonadotropic hypogonadism): 500 to 1,000 USP units 3 times a week for 3 weeks, then twice a week for 3 weeks; or 4,000 units 3 times a week for 6 to 9 months, then 2,000 units 3 times a week for 3 months1 | Studied: 12.5 or 25 mg by mouth daily in phase 3 trials6 |
| Route | Injection into muscle only, per the label7 | By mouth |
| Half-life | Not stated on the labels. Dose Track uses about 29 hours, from the Ovidrel label (recombinant hCG, under the skin)8 | Sources conflict; a single-dose study could not estimate a terminal half-life9 |
| Time to peak (Tmax) | Not stated on the Novarel or Pregnyl labels | About 3 hours after a clomiphene dose9 |
| Effect on sperm | Not addressed in the label dosing sections | Sperm concentration kept in the normal range vs a marked fall on testosterone gel3 |
| Strengths | 5,000 and 10,000 unit vials (powder) | No approved product |
| Notable label warnings | Label statement (in capitals) that hCG is not effective for obesity; precocious puberty when treating cryptorchidism; ovarian hyperstimulation in women1 | No label. In phase 3, 14.2% on drug vs 2.6% to 4.3% on placebo had a 50% or larger drop in sperm concentration610 |
Testosterone therapy suppresses the brain's LH and FSH signals, which can lower sperm production. hCG replaces the LH signal directly. Enclomiphene works one step earlier, raising the body's own LH and FSH. Both are discussed for men who want to keep testicular function, but only hCG is FDA approved, and its approved male use is hypogonadotropic hypogonadism.1
FDA declined to approve it in 2015, saying the phase 3 design was no longer adequate to show clinical benefit.2